What is EYPT's current stock price?

As of now, EYPT is trading at $11.83, with a daily change of -3.31%.

What are the risks associated with EYPT stock?

EYPT Key risk is its Moderate Risk Level, .

What is EYPT next earnings date?

EYPT next earnings report is scheduled for Nov 5, 2025.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Earnings Calendar Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

EYPT Stock Analysis & IQ Rating | EyePoint Pharmaceuti

EYPT

EyePoint Pharmaceuti

$11.83

-$0.42 | -3.31%

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Headlines

52W High

$ 14.91

MKT CAP

$ 956.08M

52W Low

$ 3.91

VOL

$ 418.87K

P/E Ratio

N/A

AVG VOL

$ 1.31M

RSI

41.68

TREND

Sideways

EYPT Stock IQ

Login to see EyePoint Pharmaceuti (EYPT) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

EYPT Target Price

Login to display

Strengths

EYPT Rewards

Earnings are forecast to grow

Chart

$12.92 (-8.44%)

$10.89 (+8.63%)

$8.94 (+32.33%)

$12 (-1.42%)

1year

6month

3month

1month

EYPT Risk Level

EYPT has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

LOW

HIGH

EYPT Analysts Opinion

EYPT overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

EYPT Analysts Opinion

EYPT Analysts opinion is negative and it remained unchanged from the past 3 months

EYPT Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

89%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

NA

100%

EYPT Street Opinion

EYPT Street view is extremely bullish and have positive views on the near-term outlook

EYPT Performance Sentiment

Sentiments overview associated with EYPT events and the stock performance.

89%

11%

Positive

Negative

8 out of 9
events present

1 out of 9
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$11.98

Resistance
Price

$10.82

Current Price Range

$14.24

Show methods +

EYPT Earnings

The TTM reflects 12-month period, providing review of EYPT financial performance.

Millions of Dollars

TTM

2024

2023

CAGR

Total Revenue

52

43

46

+6.32%

Cost of Revenue

3

4

5

-22.54%

Gross Profit

49

40

41

+9.32%

Operating Exp

238

185

116

+43.24%

Operating Inc

-189

-146

-75

-

Net Interest Inc

14

15

6

+52.75%

Interest Exp

-

1

-

Interest Inc

14

15

7

+41.42%

Other Inc Exp

-

-1

-

EPS Growth

-2.69

-2.32

-1.82

-

EYPT Financial Health

The company financial health has moderately improved over the past year

Financial Score

3.65

Next Earnings Date: Nov 5, 2025

EYPT Latest Analysis +

FAQ About EYPT Stock Insights

What is EYPT current stock price?

What are EYPT stock strengths?

What risks are associated with EYPT stock?

When is EYPT next earnings report?

What is EYPT market cap and volume?

What is EYPT's current Stock IQ?

Should I buy EYPT stock right now?

Is EYPT a Strong Buy right now?

What does a 'Strong Buy' rating mean for EYPT?

What does a 'Strong Sell' rating mean for EYPT?

What factors influence EYPT's Stock IQ?

Explore our EYPT Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored EYPT Stock Strategies
Effective Risk Management

FIND US ON

Receive our EYPT Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

EYPT

EyePoint Pharmaceuti

Current Price

$11.83

-$0.42 | -3.31%

52W High

$ 14.91

MKT CAP

$ 956.08M

52W Low

$ 3.91

VOL

$ 418.87K

P/E Ratio

N/A

AVG VOL

$ 1.31M

RSI

41.68

TREND

Sideways

Create Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Earnings

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

EYPT Rewards

Earnings are forecast to grow

EYPT Stock IQ

Login to unlock EyePoint Pharmaceuti (EYPT) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

Chart

$12.92 (-8.44%)

$10.89 (+8.63%)

$8.94 (+32.33%)

$12 (-1.42%)

1year

6month

3month

1month

EYPT Analysts Opinion

EYPT Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

EYPT Analysts Opinion

EYPT Analysts opinion is negative and it remained unchanged from the past 3 months

EYPT Street Consensus

Analysts perspectives on the stock desirability, trend direction, and growth potential.

89%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

NA

100%

EYPT Street Opinion

EYPT Street view is extremely bullish and have positive views on the near-term outlook

EYPT Risk Level

EYPT has Moderate Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

Risks Indicators

Beta greater than 1.0

LOW

HIGH

EYPT Performance Sentiment

Sentiments overview associated with EYPT events and the stock performance.

89%

11%

Positive

Negative

8 out of 9
events present

1 out of 9
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels.

Login to display

Support
Price

$11.98

Resistance
Price

$10.82

Current Price Range

$14.24

Show methods +

EYPT Earnings

The TTM data reflects the most recent 12-month period, providing overview of EYPT financial performance.

Millions of Dollars

TTM

2024

2023

CAGR

Total Revenue

52

43

46

+6.32%

Cost of Revenue

3

4

5

-22.54%

Gross Profit

49

40

41

+9.32%

Operating Exp

238

185

116

+43.24%

Operating Inc

-189

-146

-75

-

Net Interest Inc

14

15

6

+52.75%

Interest Exp

-

1

-

Interest Inc

14

15

7

+41.42%

Other Inc Exp

-

-1

-

EPS Growth

-2.69

-2.32

-1.82

-

EYPT Financial Health

The company financial health has moderately improved over the past year

Financial Score

3.65

Next Earnings Date: Nov 5, 2025

EYPT Latest Analysis

EyePoint: Uncompelling Non-Inferiority Strategy Vs. A Moving Aflibercept Target.

Thu Oct 16, 2025

$11.55 | -1.53%

Potential

EyePoint Pharmaceuticals Raises Capital As It Advances Lead Product To Pivotal Study. EYPT) shared details on Tuesday about its pivotal Phase 3 program of Duravyu (vorolanib intravitreal insert) for diabetic macular edema (DME) and began first patient dosing anticipated in the .DME is the leading cause of vision loss in type 1 and type 2 diabetes patients. Damaged blood vessels leak fluid into the macula the central portion of the retina responsible for sharp vision needed for routine tasks .The

Wed Oct 15, 2025

$11.73 | -10.87%

Activity

EyePoint prices public offering at $12.00 per share raises $150M to boost DURAVYU™ Phase 3 clinical programs.

Wed Oct 15, 2025

$11.73 | -10.87%

Activity

EyePoint Announces Pricing of Public Offering. ) a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases today announced the pricing of an underwritten public offering of 11000000 shares of its common stock at a public offering price of $12.00 per share and to certain investors in lieu of common stock pre-funded warrants to purchase up to an aggregate of 1500000 shares of its common stock at a price to the publi

Wed Oct 15, 2025

$11.73 | -10.87%

Activity

Potential

EyePoint announces proposed public offering of common stock.

Tue Oct 14, 2025

$13.16 | -1.35%

Activity

Discover EYPT Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of EYPT. We're here to help you make informed investment decisions today.

FIND US ON

Receive our EYPT Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

EYPT Stock trends

EYPT Stock performance

EYPT Stock analysis

EYPT investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing EYPT

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing EYPT

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence, and cutting-edge intelligence.

EYPT Stock Analysis & IQ Rating | EyePoint Pharmaceuti

EYPT Stock IQ

EYPT Target Price

EYPT Risk Level

EYPT Analysts Opinion

EYPT Street Consensus

EYPT Performance Sentiment

Technical Price Levels

EYPT Financial Health

Explore our EYPT Stock insights

Receive our EYPT Daily Alerts

EYPT Stock IQ

EYPT Street Consensus

EYPT Risk Level

Technical Price Levels

Discover EYPT Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends, and the future potential of EYPT. We're here to help you make informed investment decisions today.

Receive our EYPT Daily Alerts

EYPT Runner Alarm